Made in Oslo, the first ever Norwegian CAR T cell is now a fact.
A second group of patients have been added to an ongoing phase II clinical study of a drug combination to treat lung cancer.
How can the voices of cancer patients be heard when evaluating new methods of treatment?
Students were taught about the chemistry behind developing cancer treatments in the Oslo Cancer Cluster Incubator.
Student Jørgen Amdim got to experience life as an orderly at the Radium Hospital.
A new study may potentially enable scientists to provide cancer immunotherapy that is cheaper, faster and more manageable.